Ifosfamide
From Wikipedia, the free encyclopedia
Ifosfamide
|
|
Systematic (IUPAC) name | |
3-(2-chloroethyl)-2 -[(2-chloroethyl)amino]tetrahydro -2H-1,3,2-oxazaphosphorine 2-oxide |
|
Identifiers | |
CAS number | |
ATC code | L01 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C7H15Cl2N2O2P |
Mol. mass | 261.1 |
Pharmacokinetic data | |
Bioavailability | 100% |
Metabolism | Hepatic |
Half life | 60-80% in 72 hours |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
? |
Routes | intravenously |
Ifosfamide (pronounced eye.fos'.fa.mide) (also marketed as Mitoxana and Ifex) is a white powder which, when prepared for use in chemotherapy becomes a clear, colorless fluid. The delivery is intravenous, and is given as a treatment for a variety of cancers, including:
- Testicular cancer
- Breast cancer
- Lymphoma (Non-Hodgkin)
- Soft tissue sarcoma
- Osteogenic sarcoma
- Lung cancer
- Cervical cancer
- Ovarian cancer
- Bone cancer
Ifosfamide is often used in conjunction with Mesna to avoid internal bleeding in the patient.
[edit] External links
- ACS Drug Guide: Ifosfamide
- Harvard Medical School Health Information on Ifosfamide
- MedlinePlus Drug Information
- BC Cancer Agency Ifosamide Information (Professional)
- RxList Online Drug Index Ifosamide Listing